AC Immune is a biopharmaceutical firm that develops therapeutics for alzheimer and other neurodegenerative diseases.
Business Model:
Revenue: $17.5M
Employees: 51-200
Address: EPFL Innovation Park
City: Lausanne
State: vaud
Zip: 1015
Country: CH
AC Immune is a biopharmaceutical firm that develops therapeutics for alzheimer and other neurodegenerative diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
5/31/2016
Ticker Symbol:
ACIU
IPO Price:
$11.071967790639153/share
Amount Raised:
$50M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2016 | Series E | 1 | $43.5M |
Dietmar Hopp Dietmar Hopp Dietmar Hopp Dietmar Hopp |
5/2005 | Series B | $17.5M | 9/2016 | IPO | $66M | 1/2009 | Series C | $30.4M | 1/2014 | Series D | $21.9M | 1/2009 | Series C | $34.6M | 1/2014 | Series D | $0 |
dievini Hopp Biotech Holding dievini Hopp Biotech Holding dievini Hopp Biotech Holding dievini Hopp Biotech Holding |
5/2005 | Series B | $17.3M | 1/2014 | Series D | 1 | $22M |
dievini Hopp Biotech Holding dievini Hopp Biotech Holding dievini Hopp Biotech Holding dievini Hopp Biotech Holding |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|